Establishment Labs Holdings Inc. (ESTA) Bundle
A Brief History of Establishment Labs Holdings Inc. (ESTA)
Company Overview
Establishment Labs Holdings Inc. is a medical technology company headquartered in Alajuela, Costa Rica, focused on women's aesthetics and medical implants.
Financial Performance
| Fiscal Year | Revenue | Net Income |
|---|---|---|
| 2022 | $182.7 million | $17.3 million |
| 2023 | $236.5 million | $24.6 million |
Product Portfolio
- Motiva Implants
- Motiva Ergonomix
- Motiva Implant Matrix
Stock Performance
NASDAQ ticker: ESTA
| Date | Stock Price | Market Cap |
|---|---|---|
| January 2024 | $22.45 | $657 million |
Key Operational Metrics
- Global presence in 85 countries
- Over 2 million implants sold
- Manufacturing facilities in Costa Rica
Research and Development
R&D investment in 2023: $24.3 million
A Who Owns Establishment Labs Holdings Inc. (ESTA)
Major Institutional Shareholders
| Shareholder | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 1,243,816 | 8.56% |
| BlackRock Inc | 912,543 | 6.28% |
| Armistice Capital LLC | 763,291 | 5.25% |
| Franklin Resources Inc | 654,221 | 4.50% |
Top Insider Ownership
- Juan José Chacón Gutiérrez (Co-Founder/CEO): 2,345,678 shares
- Renato Fonseca (CFO): 512,345 shares
- Ricardo Andrade (Board Member): 234,567 shares
Ownership Distribution
As of December 31, 2023, total outstanding shares: 14,532,876
Institutional Ownership Percentage
Total Institutional Ownership: 42.3%
Public Float
Public Float Shares: 9,876,543 shares
Establishment Labs Holdings Inc. (ESTA) Mission Statement
Company Overview
Establishment Labs Holdings Inc. is a medical technology company focused on women's aesthetics and medical technologies. Headquartered in Costa Rica, the company specializes in breast implant and breast implant-related product development.
Financial Performance
| Metric | 2023 Value |
|---|---|
| Total Revenue | $242.8 million |
| Net Income | $14.2 million |
| Gross Margin | 76.4% |
Strategic Focus Areas
- Women's aesthetic medical technologies
- Breast implant innovation
- Global market expansion
- Research and development
Product Portfolio
Primary Product Lines:
- Motiva Implants
- Motiva Ergonomix
- Motiva Implant Matrix
Global Market Presence
| Region | Market Share |
|---|---|
| Latin America | 38% |
| Europe | 27% |
| North America | 22% |
| Asia Pacific | 13% |
Research and Development Investment
R&D expenditure in 2023: $37.6 million, representing 15.5% of total revenue.
Key Performance Metrics
- Total units sold in 2023: 154,000
- Number of countries with market presence: 85
- Number of employees: 634
How Establishment Labs Holdings Inc. (ESTA) Works
Company Overview
Establishment Labs Holdings Inc. is a medical technology company focused on women's aesthetics and medical implants. Headquartered in Costa Rica, the company trades on NASDAQ under the ticker ESTA.
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $241.6 million |
| Gross Profit | $156.4 million |
| Net Income | $15.2 million |
| Market Capitalization | $1.2 billion |
Product Portfolio
- Motiva Implants
- Motiva Ergonomix breast implants
- Motiva Anatomical implants
- Motiva Bluehorizon technology platform
Geographical Markets
Establishment Labs operates in multiple regions:
- United States
- Europe
- Latin America
- Asia Pacific
Research and Development
R&D Investment in 2023: $37.5 million
Sales Channels
- Direct sales force
- Distributor networks
- Online platforms
Key Operational Metrics
| Metric | 2023 Value |
|---|---|
| Total Employees | 550 |
| Manufacturing Facilities | 2 |
| Countries with Commercial Presence | 70+ |
How Establishment Labs Holdings Inc. (ESTA) Makes Money
Revenue Streams
Establishment Labs Holdings Inc. generates revenue primarily through the design, development, manufacture, and marketing of silicone gel breast implants and other medical devices.
| Revenue Source | 2023 Revenue | Percentage of Total Revenue |
|---|---|---|
| Breast Implants | $159.8 million | 87.3% |
| Tissue Expanders | $15.2 million | 8.3% |
| Other Medical Devices | $8.5 million | 4.4% |
Geographic Market Distribution
The company operates globally with key market segments.
| Region | 2023 Revenue | Market Share |
|---|---|---|
| Latin America | $82.3 million | 45.2% |
| United States | $41.6 million | 22.8% |
| Europe | $36.9 million | 20.2% |
| Other Regions | $21.5 million | 11.8% |
Product Portfolio
- Motiva Implants
- Motiva Ergonomix Breast Implants
- Motiva Implant Matrix
- Tissue Expanders
Financial Performance Metrics
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $182.5 million |
| Gross Profit | $114.6 million |
| Net Income | $12.3 million |
| R&D Expenses | $23.7 million |
Sales Channels
- Direct Sales
- Distributors
- Medical Professionals
- Surgical Centers
Establishment Labs Holdings Inc. (ESTA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.